Metronidazole treatment of women with a positive fetal fibronectin test result
- PMID: 11518914
- DOI: 10.1067/mob.2001.115998
Metronidazole treatment of women with a positive fetal fibronectin test result
Abstract
Eighty-nine women with either bacterial vaginosis, Trichomonas vaginalis, or both, who also had a positive fetal fibronectin test result were randomized to two courses of metronidazole treatment as part of a Maternal-Fetal Medicine Network Units study of the National Institute of Child Health and Human Development. In this subgroup analysis, compared with the placebo group, women who were treated with metronidazole had a nonsignificant reduction in spontaneous preterm birth from 14.6% to 8.3%.
Comment in
-
Antimicrobials in the prevention of prematurity.Am J Obstet Gynecol. 2002 May;186(5):1106-7; author reply 1107. doi: 10.1067/mob.2002.122979. Am J Obstet Gynecol. 2002. PMID: 12015547 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
- U10 HD 21410/HD/NICHD NIH HHS/United States
- U10 HD 21414/HD/NICHD NIH HHS/United States
- U10 HD 27869/HD/NICHD NIH HHS/United States
- U10 HD 27917/HD/NICHD NIH HHS/United States
- U10 HD27860/HD/NICHD NIH HHS/United States
- U10 HD27861/HD/NICHD NIH HHS/United States
- U10 HD27905/HD/NICHD NIH HHS/United States
- U10 HD27915/HD/NICHD NIH HHS/United States
- U10 HD34116/HD/NICHD NIH HHS/United States
- U10 HD34122/HD/NICHD NIH HHS/United States
- U10 HD34136/HD/NICHD NIH HHS/United States
- U10 HD34208/HD/NICHD NIH HHS/United States
- U10 HD34210/HD/NICHD NIH HHS/United States
- U10 HD36801/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources